Andrew C. Cooper - Concepedia

Author

Andrew C. Cooper

Also Known As

Andrew C. Cooper, Andrew Cooper

Publications

368

Citations

H-Index

Concepts

All Affiliations

Andrew C. Cooper is an author at Repligen (United States) specializing in medicine, genetics, and chromatin.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	280
2	Cell Biology	2	2	120
3	Engineering	1	1	40
4	Applied Physics	1	1	40
5	Biomedical Engineering	1	1	40

Andrew C. Cooper

Publications

367

Citations

H-Index

Page 1

	Year	Citations
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease Haiqun Jia, Judit Pallos, Vincent Jacques, Neurobiology of Disease ChromatinChromatin RemodelingEpigenetic ChangeGeneticsPolyglutamine-elicited Phenotypes	2012	160
Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma Christina E. Wells, Srividya Bhaskara, Kristy R. Stengel, PLoS ONE Histone ModificationsPathologyDermatologyHdac3 InhibitionHdac Activities	2013	103
Superlubricity in Gemini Hydrogels Angela A. Pitenis, Juan Manuel Urueña, Andrew C. Cooper, Journal of Tribology Thermal FluctuationsEngineeringMechanical EngineeringWettingContact Areas	2016	40
Evaluation of Histone Deacetylase Inhibitors as Therapeutics for Neurodegenerative Diseases Elisabetta Soragni, Chunping Xu, Andrew C. Cooper, Methods in molecular biology	2011	27
A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non–Hodgkin's Lymphoma Cell Proliferation <i>In vitro</i> and <i>In vivo</i> Andrew C. Cooper, Russell Karp, Edward J. Clark, Clinical Cancer Research	2006	20
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice Daniel J. Amante, Jin-Ho Kim, Samantha Carreiro, Amyotrophic Lateral Sclerosis GeneticsVentral Horn AtrophyNeurochemical BiomarkersExperimental PharmacologyOxidative Stress	2010	17

Page 1